首页 > 市场调查报告书 > 医疗设备

生技设备

血浆疗法市场规模、份额和成长分析（按类型、来源、应用、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1903152

血浆疗法市场规模、份额和成长分析（按类型、来源、应用、最终用户和地区划分）—产业预测（2026-2033 年）

Plasma Therapy Market Size, Share, and Growth Analysis, By Type (Pure PRP, Leukocyte-Rich PRP), By Source (Autologous, Allogenic), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球血浆疗法市场规模将达到 3.5433 亿美元，到 2025 年将成长至 4.05 亿美元，到 2033 年将成长至 11.7984 亿美元，在预测期（2026-2033 年）内复合年增长率为 14.3%。

受男性型脱髮症和运动伤害发病率上升的推动，全球血浆疗法正经历显着增长。由于血浆中含有高浓度抗体，其治疗用途可将康復者的免疫力转移给患者，从而拓展了其应用范围，使其不再局限于整形外科、皮肤科和牙科。整形外科疾病盛行率的不断上升带来了更多机会，而富血小板血浆在各种治疗领域的广泛应用进一步提升了市场潜力。然而，挑战依然存在，包括报销指南不一致、成本波动以及在糖尿病和肾臟病患者中的适用性有限，这些都可能阻碍市场扩张。整体而言，随着不同患者群体需求的持续成长，市场格局正蓄势待发，即将迎来动态变化。

全球血浆疗法市场驱动因素

全球血浆疗法市场正因运动伤害发生率的上升和美容手术的激增而蓬勃发展。此外，参与各类体育活动的人数不断增加，进一步推动了对有效治疗方法的需求。同时，富血小板血浆（PRP）在研究领域的应用日益广泛，使人们对其益处和应用领域有了更深入的了解。这些因素共同推动了运动医学和美容外科领域对创新治疗方案的需求，从而促进了整个血浆疗法市场的成长和扩张。

限制全球血浆疗法市场的因素

全球血浆疗法市场成长面临许多挑战，主要原因在于该疗法的高昂费用。从血液中提取血浆以及后续储存的成本阻碍了其广泛应用，并限制了市场潜力。在许多发展中地区，治疗费用高昂限制了其普及，导致很大一部分人群无法获得此类治疗。因此，一般民众无力负担血浆疗法的费用已成为阻碍市场扩张和更广泛接受度的关键因素。

全球血浆疗法市场趋势

全球血浆疗法市场呈现显着上升趋势，主要受男性型脱髮症和整形外科疾病等疾病日益普遍的推动。对创新治疗方案需求的激增凸显了消费者对血浆疗法的接受度不断提高。然而，对糖尿病和肾臟病患者疗效有限等挑战可能会阻碍其更广泛的应用。此外，医疗技术的进步不仅使治疗方法更加多样化，也提高了包括罕见疾病在内的多种疾病的治疗成功率。公共和私营部门不断扩大服务范围，进一步推动了这一增长，使不同收入水平的患者更容易获得治疗。

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- CSL Behring（澳洲）
- 格里福尔斯公司（西班牙）
- Kedrion SpA（义大利）
- Octapharma AG（瑞士）
- 武田药品工业株式会社（日本）
- Zimmer Biomet（美国）
- 百特国际有限公司（美国）
- 中国生物製品控股有限公司（中国）
- GC製药（韩国）
- 韩国绿十字公司
- 日本血液製品机构（日本）
- LFB SA（法国）
- 上海瑞斯血液製品有限公司（中国）
- 中国物联网集团股份有限公司（CNBG）（中国）
- 广州白云山药业控股有限公司（中国）
- 江西博亚生物製药有限公司（中国）
- 生物製品实验室有限公司（BPL）（英国）
- BioLife 血浆服务（美国）
- 加拿大血浆资源公司（加拿大）

结论与建议

简介目录

Product Code: SQMIG35H2056

Global Plasma Therapy Market size was valued at USD 354.33 Million in 2024 and is poised to grow from USD 405 Million in 2025 to USD 1179.84 Million by 2033, growing at a CAGR of 14.3% during the forecast period (2026-2033).

Global Plasma Therapy is experiencing considerable growth, driven by the increasing incidence of androgenic alopecia and sports injuries. As plasma contains a high concentration of antibodies, its therapeutic use helps transfer immunity from recovered individuals to patients, with applications expanding beyond orthopaedics, dermatology, and dentistry. The rising prevalence of orthopedic disorders presents additional opportunities, while the widespread adoption of platelet-rich plasma in various therapeutic areas further boosts market potential. However, challenges remain, including inconsistent reimbursement guidelines, varying costs, and limited applicability in diabetic patients and those with kidney issues, which may hinder market expansion. Overall, the landscape is poised for dynamic changes as demand continues to rise across diverse patient demographics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Plasma Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Plasma Therapy Market Segments Analysis

Global Plasma Therapy Market is segmented by Type, Source, Application, End User and region. Based on Type, the market is segmented into Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin. Based on Source, the market is segmented into Autologous and Allogenic. Based on Application, the market is segmented into Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. Based on End User, the market is segmented into Hospitals & Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Plasma Therapy Market

The Global Plasma Therapy market is experiencing growth due to a rising incidence of sports injuries and a surge in cosmetic procedures. Additionally, there is an expanding number of individuals participating in various athletic activities, which further fuels demand for effective treatment options. Moreover, the application of platelet-rich plasma (PRP) in research settings is on the rise, contributing to advancements in understanding its benefits and applications. This combination of factors enhances the need for innovative therapeutic solutions in both sports medicine and cosmetic enhancements, thus driving the overall development and expansion of the plasma therapy market.

Restraints in the Global Plasma Therapy Market

The growth of the global plasma therapy market faces significant challenges primarily due to the high costs associated with the procedure. The expenses incurred in the extraction of plasma from blood and the subsequent storage of this plasma hinder widespread adoption and limit market potential. In many underdeveloped and developing regions, the financial burden of therapy restricts its accessibility, making it difficult for a large segment of the population to utilize these treatments. Consequently, the inability of the average individual to afford plasma therapy emerges as a critical factor obstructing the market's expansion and broader acceptance.

Market Trends of the Global Plasma Therapy Market

The Global Plasma Therapy market is witnessing a significant upward trend driven by the increasing prevalence of conditions like androgenic alopecia and orthopedic disorders. This surge in demand for innovative treatment options highlights the expanding acceptance of plasma therapy among consumers. However, challenges such as limited efficacy in diabetic and kidney disease patients may hinder broader adoption. Moreover, advancements in healthcare technologies have not only diversified treatment options but also improved the success rates across various medical conditions, including rare diseases. This growth is further supported by enhanced service offerings from public and private sectors, fostering accessibility for patients with varying disposable incomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Plasma Therapy Market Size by Type & CAGR (2026-2033)

Market Overview
Pure PRP
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin

Global Plasma Therapy Market Size by Source & CAGR (2026-2033)

Market Overview
Autologous
Allogenic

Global Plasma Therapy Market Size by Application & CAGR (2026-2033)

Market Overview
Orthopedic
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
Dermatology
- Androgenic Alopecia
- Plastic Surgery
Cardiac Muscle Injury
Dental
Nerve Injury
Others

Global Plasma Therapy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Research Institutes

Global Plasma Therapy Market Size & CAGR (2026-2033)

North America (Type, Source, Application, End User)
- US
- Canada
Europe (Type, Source, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Source, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Source, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Source, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

CSL Behring (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kedrion S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Octapharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Biologic Products Holdings, Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GC Pharma (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Green Cross Corp. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Japan Blood Products Organization (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LFB SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai RAAS Blood Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China National Biotec Group Co., Ltd. (CNBG) (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangxi Boya Bio-Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Products Laboratory Ltd. (BPL) (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Plasma Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canadian Plasma Resources (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments